About us
The biggest advantage of our company, which offers a new medical technology to the public, may be that we link research and application through our shared vision.
Numbers and facts
| Discovery of the new ABCB5 glycoprotein by Dr. Markus Frank, which marks the pluripotent stem cells in the skin | ||
| Founding of TICEBA GmbH in the year of 2003 by Dr. Christoph Ganss | ||
| Start of business activities in March 2005 | ||
| Granting of manufacturing license within the meaning of § 20 b and § 20 c in January 2009 | ||
| Offices and laboratory at technology park Heidelberg | ||
| 9 employees | ||
| Global business activities | ||
| TICEBA is a full member of the following associations: | |||
 |
European Association of Pharma Biotechnology (EAPB) | ||
 |
German Association for Regenerative Medicine (GRM) | ||
